Chris Hopkins is a serial entrepreneur. He has a PhD in biochemistry and human genetics. He is a founder of Knudra Transgenics, Axumbio, Devinebio, and Glafabra Therapeutics. Guided merger of Knudra into InVivo Biosystems. Created multiple product launches leading to over $10 M in revenue. Received over $6M in non-dilute SBIR funding. Enjoys getting into the great outdoors.